Table 5.
Cox regression of clinical-pathological variables regarding overall survival in vulvar carcinoma patients.
| Variable | Significance | Hazard Ratio of Exp (B) |
Lower 95% Confidence Interval of Exp (B) |
Upper 95% Confidence Interval of Exp (B) |
|---|---|---|---|---|
| PPARγ in cytoplasm |
0.626 | 1.193 | 0.588 | 2.418 |
| pT | 0.336 | 1.496 | 0.658 | 3.400 |
| pN | 0.403 | 0.996 | 0.985 | 1.006 |
| Grading | 0.009 | 2.016 | 1.190 | 3.413 |
| FIGO | 0.259 | 1.342 | 0.805 | 2.238 |
| p16 status | 0.061 | 0.481 | 0.224 | 1.034 |
PPARγ cytoplasm = expression of PPARγ in cytoplasm with IRS ≥ 2, pT = tumor stage, pN = nodal stage, FIGO = Classification of the International Federation of Gynecology and Obstetrics.